Education
About Us
Working with TipRanks
Follow Us
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
Ocular Therapeutix (OCUL) Ownership Overview
3.32% Insiders
9.89% Mutual Funds
48.76% Other Institutional Investors
10.56% ETFs
27.47% Public Companies and
Individual Investors
The ownership structure of Ocular Therapeutix (OCUL) stock is a mix of institutional, retail, and individual investors. Approximately 69.21% of the company’s stock is owned by Institutional Investors, 3.32% is owned by Insiders, and 27.47% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 26, 2025 | Peter Kaiser Cdo | xxxxxxxxxxxxx | $20672 |
| Feb 26, 2025 | xxxxxxxxxxxxx | $21029 | |
| Feb 26, 2025 | Pravin Dugel Executive Chairman, President And Ceo,director | xxxxxxxxxxxxx | $147533 |
| Feb 26, 2025 | Sanjay Nayak Cso | xxxxxxxxxxxxx | $12962 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $320907 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $896700 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $8560794 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $9210347 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,753,818 | Institution | 4.88% | 59,859,475 | |
| 6,702,525 | Institution | 4.21% | 51,743,493 | |
| 6,594,656 | Institution | 4.15% | 50,910,744 | |
| 3,520,318 | Insider | 2.21% | 27,176,855 | |
| 1,710,854 | Institution | 1.08% | 13,207,793 | |
| 1,299,952 | Institution | 0.82% | 10,035,629 | |
| 1,254,413 | Institution | 0.79% | 9,684,068 | |
| 1,078,495 | Institution | 0.68% | 8,325,981 | |
| 1,002,435 | Institution | 0.63% | 7,738,798 | |
| 888,486 | Institution | 0.56% | 6,859,112 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,594,656 | Institution | 4.15% | 50,910,744 | |
| 1,710,854 | Institution | 1.08% | 13,207,793 | |
| 1,299,952 | Institution | 0.82% | 10,035,629 | |
| 1,254,413 | Institution | 0.79% | 9,684,068 | |
| 888,486 | Institution | 0.56% | 6,859,112 | |
| 886,021 | Institution | 0.56% | 6,840,082 | |
| 438,853 | Institution | 0.28% | 3,387,945 | |
| 427,500 | Institution | 0.27% | 3,300,300 | |
| 410,100 | Institution | 0.26% | 3,165,972 | |
| 400,000 | Institution | 0.25% | 3,088,000 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,710,622 | Institution | 2.96% | 33,633,841 | |
| 4,201,555 | Institution | 2.64% | 32,436,005 | |
| 1,955,495 | Institution | 1.23% | 13,962,234 | |
| 1,374,435 | Institution | 0.86% | 10,610,638 | |
| 712,541 | Institution | 0.45% | 5,087,543 | |
| 592,397 | Institution | 0.37% | 4,668,088 | |
| 349,836 | Institution | 0.22% | 2,700,734 | |
| 298,091 | Institution | 0.19% | 2,128,370 | |
| 278,822 | Institution | 0.18% | 2,152,506 | |
| 243,976 | Institution | 0.15% | 1,922,531 |
FAQ
Who Owns Ocular Therapeutix (OCUL)?
According to the latest TipRanks data, approximately 48.76% of the company's stock is held by institutional investors, 3.32% is held by insiders, and 27.47% is held by retail investors.
What percentage of Ocular Therapeutix (OCUL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.76% of Ocular Therapeutix (OCUL) stock is held by institutional investors.
What percentage of Ocular Therapeutix (OCUL) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.47% of Ocular Therapeutix (OCUL) stock is held by retail investors.
Who owns the most shares of Ocular Therapeutix (OCUL)?
Vanguard owns the most shares of Ocular Therapeutix (OCUL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.